Refeyn is pleased to announce the appointment of Jean-Paul Mangeolle to its Board of Directors as a non-executive director.
Mangeolle has worked for over 35 years in the life sciences instruments industry. He retired recently from Danaher, where he had held the position of President for Sciex since 2014. Previously, he was Executive Vice President for the Process Solutions Business Unit of Merck KGaA. Mangeolle spent 25 years with Millipore Corporation, in Europe, Asia and the US.
Mangeolle has served as a director on the boards of several private and public companies. He is currently on the board of Terapore Technology and Polyplus Transfection SA. He is also a co-founder of Petri Bio, an early-stage venture capital firm, and an advisor to Azimov Bio and TPG.
Refeyn Chair Jonathan Flint said: “We are delighted that Jean-Paul will be joining Refeyn’s board. He brings a wealth of experience in building highly successful businesses in biotechnology and other key areas, and his expertise will be incredibly valuable as Refeyn continues to grow.”